Research / Unapproved

Nesiritide: Research Status And Trial Data

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC143H244N50O42S4
Molecular weight3464 g/mol
Registered trials1842
PubChem CID71308561

Regulatory Status

Nesiritide is treated here as an unapproved research compound. No FDA-approved product label is available for this profile, so approved uses, dosing context, and mechanism-of-action language cannot be summarized from label data.

What Nesiritide Is

Nesiritide is a synthetic peptide with the molecular formula C143H244N50O42S4 and a molecular weight of roughly 3,464 daltons. Its structure, cataloged under PubChem CID 71308561, reflects a large, multi-ring peptide chain typical of engineered research peptides.

Trial Footprint

ClinicalTrials.gov lists 1,842 registered studies associated with this compound record. The available sample includes a Phase 4 study on short-term intravenous fluids for preventing post-ERCP pancreatitis (recruiting), an unphased trial on exercise intervention for cardiorespiratory function in heart failure with diabetes (status unknown), and a completed study examining somatic disease among alcohol abusers in an outpatient clinic. These examples illustrate the range of registered trial activity rather than confirmed uses of the compound itself.

FAQ

Is nesiritide FDA-approved?
Based on the data available for this profile, nesiritide is classified as an unapproved research compound. No approved product label was found to reference for indications, mechanism, or dosing.
What kind of molecule is nesiritide?
It is a synthetic peptide with the molecular formula C143H244N50O42S4 and a molecular weight of about 3,464 daltons. It is cataloged in PubChem under CID 71308561.
How many clinical trials involve nesiritide?
The ClinicalTrials.gov record associated with this compound lists 1,842 registered studies. The sample data available spans different phases and statuses, from recruiting to completed.
Do the sample trials prove nesiritide is effective for a condition?
No. The listed trials, including studies on post-ERCP pancreatitis prevention and heart failure exercise intervention, are examples of registered trial activity only. They do not establish efficacy or an approved use for nesiritide.
Are there reported side effects for nesiritide in this profile?
No adverse event report data was available for this compound in the dataset used to build this profile, so no side effect summary can be provided here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-08-03